Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Aon to Host 2025 Investor Day on June 9
-
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
-
Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering
-
The St. Joe Company Announces Plans for a Publix Super Market at Watersound® West Bay Center Along With Additional Leasable Commercial Space
-
BGC Group Announces Schedule Update for Piper Sandler Global Exchange & Trading Conference on June 5, 2025
-
Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
-
Allurion to Present at Jefferies Global Healthcare Conference
-
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
-
Mondelēz International Expands Sustainable Futures Portfolio Aiming to Accelerate Scalable Climate and Community Initiatives
-
Sunrise Realty Trust Expands Revolving Credit Facility to $140 Million with Addition of EverBank as Joint Lead Arranger
-
Autolus Therapeutics to Participate in Upcoming Investor Conferences
-
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
-
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
-
Latham Group, Inc. to Participate at Upcoming Conferences in June 2025
-
Zeo Energy Corp. Receives Nasdaq Notice on Late Filing of its Form 10-Q
-
Parsons Celebrates Engineering Excellence Award and Ribbon Cutting for I-80/Gilman Street Interchange Project
-
ChampionsGate Acquisition Corporation Announces Closing of $74,750,000 Initial Public Offering
-
Color Star Announces a Significant Milestone in its Cryptocurrency Mining Business
-
Amneal to Participate at Upcoming Investor Conferences in June
-
The Lovesac Company Announces First Quarter Conference Call Date
-
Superior Group of Companies to Participate in the Noble Capital Markets Emerging Growth Conference
-
AGM Group Holdings Inc. Announces Effective Date of 50 for 1 Share Consolidation
-
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
-
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17
-
Seacoast Announces the Acquisition of Villages Bancorporation, Inc.
-
ScanTech AI to Attend 10th Annual Smart Airport Conference & Exposition
-
ScanTech AI to Attend 10th Annual Smart Airport Conference & Exposition
-
Vitable Health Becomes Nationwide Virtual Primary Care Partner for Apaly, Expanding Advanced Primary Care Access for Enterprise Employees
-
ESGold Advances to Next Stage of Growth with Strategic Leadership Transition
-
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CODI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Diversified Holdings Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
The Nike NFTs INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nike-themed non-fungible tokens ("NFTs") Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
NSSC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that NAPCO Security Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
NetApp Reports Record Results for Fourth Quarter and Fiscal Year 2025
-
Scholastic Announces Strategic Integration of Trade Publishing, Book Fairs and Book Clubs as New Children's Book Group to Expand Reach and Value of Scholastic Publishing
-
Robert Schriesheim Appointed Interim Chief Financial Officer of Skyworks
-
Arcturus Therapeutics to Attend Upcoming Investor Conferences
-
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
-
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
-
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
-
Central 1 reports first quarter 2025 financial results
-
The 20th Annual Russell Ferber Foundation Comedy FUNdraiser Returns to NYC
-
NobelClad Celebrates Expansion of Its Dunbar Mine in Collaboration With U.S. Navy and Partner Organizations
-
Grace Design Studios Launches as Fully Integrated National Leader in Multidisciplinary AEC Services
-
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
